In contrast, another meta-analysis conducted on non-obese women with PCOS, including 5 studies with 414 participants, reported varying degrees of increased chemerin serum levels in non-obese PCOS patients compared to the non-obese control group, which reached statistical significance (p < 0.03) [141]. This evidence concerns the gene RARRES2 and polycystic ovary syndrome.